8-K
filed May 26, 2026, 5:20 PM ET
ticker DTIL
CIK 0001357874
other material
confidence high
sentiment neutral
materiality 0.40
Precision BioSciences shareholders approve 3.8M share increase for equity plan; elect directors
PRECISION BIOSCIENCES INC
- Shareholders approved amendment to 2019 Incentive Award Plan, increasing share reserve by 3.8M shares (58% for, 42% against).
- Amendment to certificate of incorporation approved (17.9M for, 1.4M against) to allow officer exculpation under Delaware law.
- Melinda Brown and Geno Germano elected as Class I directors (14.3M and 14.3M votes for respectively).
- Ratified Deloitte & Touche as independent auditor for FY2026 (22.2M for, 99k against).
- Advisory say-on-pay approved (18.7M for, 613k against).
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
PRECISION BIOSCIENCES INC: Amended certificate of incorporation to provide for exculpation of certain officers as permitted by Delaware law (effective 2026-05-22).
- Change
- charter amendment
- Effective
- 2026-05-22
Exact text from the filing
On May 22, 2026, the Company filed the 2026 Amendment with the Secretary of State of the State of Delaware, and the 2026 Amendment became effective upon filing.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PRECISION BIOSCIENCES INC shareholders approved Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the other proposals. at the 2026-05-21 meeting.
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Item 6 – Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the other proposals. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 16,653,283 5,647,737 3,847 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PRECISION BIOSCIENCES INC shareholders approved Approval of the amendment and restatement of the Company’s 2019 Incentive Award Plan. at the 2026-05-21 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Item 4 – Approval of the amendment and restatement of the Company’s 2019 Incentive Award Plan. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 11,170,635 8,145,992 10,906 2,977,334
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PRECISION BIOSCIENCES INC shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. at the 2026-05-21 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Item 3 – Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 18,696,193 612,836 18,504 2,977,334
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PRECISION BIOSCIENCES INC shareholders approved Approval of an amendment to the Company’s Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation. at the 2026-05-21 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Item 5 – Approval of an amendment to the Company’s Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 17,909,703 1,411,694 6,136 2,977,334
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PRECISION BIOSCIENCES INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. at the 2026-05-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 22,198,597 99,879 6,391 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PRECISION BIOSCIENCES INC shareholders approved Election of two Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. at the 2026-05-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Item 1 – Election of two Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes Melinda Brown 14,348,888 4,978,645 2,977,334 Geno Germano 14,288,270 5,039,263 2,977,334
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.